BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 512074)

  • 1. Topical phosphonoacetic acid treatment of cutaneous herpes simplex infections in the guinea pig.
    McCarty JR; Jarratt MT
    J Am Acad Dermatol; 1979 Sep; 1(3):244-8. PubMed ID: 512074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disodium phosphonoacetate in cream base as a possible topical treatment for skin lesions of herpes simplex virus in cebus monkeys.
    Palmer AE; London WT; Sever JL
    Antimicrob Agents Chemother; 1977 Oct; 12(4):510-2. PubMed ID: 411417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
    J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Poryo A; Wigand R
    Med Microbiol Immunol; 1984; 173(4):219-24. PubMed ID: 6096685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of trisodium phosphonoformate on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Dinter Z; Oberg B
    Antimicrob Agents Chemother; 1978 Sep; 14(3):408-13. PubMed ID: 213015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the effectiveness of acycloguanosine and phosphonoacetic acid in herpetic infection in cell cultures].
    L'vov ND; Samoĭlovich EO; Barinskiĭ IF
    Vopr Virusol; 1986; 31(2):210-6. PubMed ID: 3014751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, caffeic acid oxidation product, and trisodiumphosphonoformate on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Helbig B; Sauerbrei A; Klöcking R; Wutzler P; Wicht N; Wiedemann U; Herrmann G
    J Med Virol; 1987 Nov; 23(3):303-9. PubMed ID: 2828526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Spruance SL; Freeman DJ; Sheth NV
    Antimicrob Agents Chemother; 1986 Jul; 30(1):196-8. PubMed ID: 2944480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic effects of five antiviral agents on cutaneous herpesvirus infection in guinea pigs.
    Alenius S; Oberg B
    Arch Virol; 1978; 58(4):277-88. PubMed ID: 736794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orofacial herpes simplex virus infection in hairless mice: latent virus in trigeminal ganglia after topical antiviral treatment.
    Klein RJ; Friedman-Kien AE; Yellin PB
    Infect Immun; 1978 Apr; 20(1):130-5. PubMed ID: 208970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of phosphonoformate on symptomatic genital herpes simplex virus type 2 infection of guinea pigs.
    Mayo DR; Lucia HL; Hsiung GD
    Intervirology; 1983; 19(1):26-32. PubMed ID: 6298142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.
    Ulbricht A; Färber I; Wutzler P
    Acta Virol; 1985 Dec; 29(6):493-8. PubMed ID: 2869661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent infections of sensory ganglia as influenced by phosphonoformate treatment of herpes simplex virus-induced skin infections in hairless mice.
    Klein RJ; DeStefano E; Brady E; Friedman-Kien AE
    Antimicrob Agents Chemother; 1979 Sep; 16(3):266-70. PubMed ID: 507784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effect of pyrophosphate analogues on cutaneous herpes simplex virus type 1 infection in guinea pigs.
    Wutzler P; Helbig B; Ulbricht A; Meerbach A; Pradel W
    Antiviral Res; 1988 Nov; 10(1-3):99-106. PubMed ID: 2852923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of topical foscarnet in a new model of herpes simplex skin infection.
    van Genderen J; Wolthuis OL; Ariens AT; Ericson AC; Datema R
    J Antimicrob Chemother; 1987 Oct; 20(4):547-56. PubMed ID: 2960644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous herpes simplex virus infections.
    Arbesfeld DM; Thomas I
    Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.